Cargando…
Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
Autores principales: | Peeters, Stijn A, Engelen, Lian, Buijs, Jacqueline, Chaturvedi, Nish, Fuller, John H, Schalkwijk, Casper G, Stehouwer, Coen D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587827/ https://www.ncbi.nlm.nih.gov/pubmed/26415611 http://dx.doi.org/10.1186/s12933-015-0290-4 |
Ejemplares similares
-
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015) -
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Engelen, Lian, et al.
Publicado: (2014) -
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study
por: Gruden, Gabriella, et al.
Publicado: (2012) -
Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies
por: Peeters, Stijn A., et al.
Publicado: (2017) -
Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study
por: Burt, Davina, et al.
Publicado: (2009)